SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cytune Pharma SAS is Granted an EU Patent for Its Potent Immunotherapy CYP0150: an Optimized Recombinant Il-15 Fusion Protein and Will Attend BIO 2012 After a Year of Achievements